---
created: 2025-04-13
updated: 2025-04-13T10:52
id: Po/a[qgn]Y
specialty: pharmaco
specialty_id: 237
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::!flag-these-cards::potential-duplicates
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::01-coagulation
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::03-hypercoagulable-states
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::02-unfractionated-heparin
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::04-heparin-vs-warfarin
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::04-heparin-vs-warfarin::heparin
  - "source/ak-step1-v11:": 
  - theme/nbme::16
  - "source/ak-step1-v11:": 
  - theme/nbme::26
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::heparin-lmwh-fondaparinux
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::heparin
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::01-heparin,-lmwh,-fondaparinux,-direct-thrombin-inhibitors,-xa-inhibitors
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1077
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1784
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::18000-18999::18727
  - source/ak-step1-v11::^other::^highyield::1-highyield
type: flashcard
---

# Question
Heparin, a common anticoagulant and treatment of DVT, pulmonary embolism, and acute coronary sd., exerts its effects by activating / potentiating the action of **antithrombin III** to cause the inhibition of thrombin and factor Xa

---

# Answer
HIT, a potential complication, is an Ab-mediated reaction to heparin-PLT factor 4 complexes == abnormal actv of PLTs == thrombocytopenia 'n' arterial or venous thromboembolic disease